1. Infusion systems
    1. Plastic bag:
      1. Contains no vacuum - needs no air to replace fluid as it flows from container.
      2. Medication can be added with syringe through a resealable latex port.
        1. During infusion, administration set should be completely clamped before medications are added
        2. Prevents undiluted, and perhaps toxic, dose from entering administration set.
    2. Closed system:
      1. Requires partial vacuum - however, only filtered air enters container.
      2. Medication may be added during infusion through air vent in administration set.
    3. Administration sets:
      1. Standard sets - deliver 10-15 drops/mL
      2. Pediatric or niinidrop sets - deliver 60 drops/ mL.
      3. Controlled-volume sets - permit accurate infusion of measured volumes of fluids.
        1. Particularly valuable when piggybacked into primary infusion.
        2. Solutions containing drugs can then be administered intermittently.
      4. Y-type administration sets - allow for simultaneous or alternate infusion of two fluids.
        1. May contain filter and pressure unit for blood transfusions.
        2. Air embolism significant hazard with this type of administration set.
      5. Positive-pressure sets - designed for rapid infusion of replacement fluids.
        1. In emergency, built-in pressure chamber increases rate of blood administration.
        2. Pump chamber must be filled at all times to avoid air embolism.
        3. Application of positive pressure to infusion fluids is responsibility of physician.
      6. Infusion pumps - used to deliver small volumes of fluid or doses of high-potency drugs.
        1. Used primarily in neonatal, pediatric, and adult intensive care units.
        2. Have increased the safety of parenteral therapy and reduced nursing time

  2. Fluid administration
    1. Factors influencing rate:
      1. Patient’s size
      2. Patient’s physical condition.
      3. Age of patient.
      4. Type of fluid
      5. Patient’s tolerance to fluid
      6. Patient’s position.
    2. Flow rates for parenteral infusions can be computed using the following formula:

      gtt/mL of given set
      60 min/hr
      X total volume/hr = gtt/min

      E.g., if 1000 mL is to be infused in an 8 hours (125 mL/hr) period and the administration set delivers 15 gtt/mL, the rate is 32 gtt/min:
      15
      60
      X 125 = 1
      4
      X 125 = 32 gtt/min
    3. Generally the type of fluid administration set determines its rate of flow.
      1. Fluid administration sets - approximately 15 gtt/min.
      2. Blood administration sets - approximately 10 gtt/min.
      3. Pediatric administration sets - approximately 60 gtt/min.
      4. Always check information on the administration set box to determine the number of gtt/mL before calculating; varies with manufacturer.
    4. Factors influencing flow rates:
      1. Gravity - a change in the height of the infusion bottle will increase or decrease the rate of flow; for example, raising the bottle higher will increase the rate of flow, and vice vers
      2. Blood clot in needle - stopping the infusion for any reason or an increase in venous pressure may result in partial or total obstruction of needle by clot due to:
        1. Delay in changing infusion bottl
        2. Blood pressure cuff on, or restraints on or above infusion needle
        3. Patient lying on arm in which infusion is being mad
      3. Change in needle position - against or away from vein wall.
      4. Venous spasm - due to cold blood or irritating solution.
      5. Plugged vent - causes infusion to stop.

  3. Fluid and electrolyte therapy
    1. Types of therapy:
      1. Maintenance therapy - provides water, electrolytes, glucose, vitamins, and in some instances protein to meet daily requirements.
      2. Restoration of deficits - in addition to maintenance therapy, fluid and electrolytes are added to replace previous losses.
      3. Replacement therapy - infusions to replace current losses in fluid and electrolytes.


    2. Commonly Used Intravenous Fluids
      IV Solution Na (mEq/L) K (mEq/L) Ca (mEq/L) Cl (mEq/L) Lactate (mEq/L) Calories/L
      0,9% NaCl (NS) 154 0 0 154 0 0
      5% Dextrose (D SW) 0 0 0 0 0 170
      5% Dextrose + 0.9% NaCl (D5 1/2 NS) 154 0 0 154 0 170
      5% Dextrose + 0.45% NaCl (D5 1/2 NS) 77 0 0 77 0 170
      Lactated Ringer’s solution 130 3 3 109 28 9
      3% NaCl 462 0 0 462 0 0
      5% NaCl 770 0 0 770 0 0
      0.45% NaCl 69.3 0 0 69.3 0 0
      10% Dextrose (D wW) 0 0 0 0 0 340



    3. Types of intravenous fluids
      1. Isotonic solutions - fluids that approximate the osmolarity (280-300 mOsm/L) of normal blood plasma
        1. Sodium chloride (0.9%) - normal salin
          1. Indications:
            1. Extracellular fluid replacement when Cl- loss is equal to or greater than Na + loss.
            2. Treatment of metabolic alkalosis.
            3. Na + depletion.
            4. Initiating and terminating blood transfusions.
          2. Possible side effects:
            1. Hypernatremi
            2. Acidosis.
            3. Hypokalemi
            4. Circulatory overloa
        2. Five percent dextrose in water (D 5W).
          1. Provides calories for energy, sparing body protein and preventing ketosis resulting from fat breakdown.
            1. 75 calories are provided per gram of glucos
            2. USP standards require use of monohydrated glucose, so only 91% is actually glucos
            3. D 5W yields 170.6 calories; D SW means 5 g glucose/100 mL water.
              50 X 75 = 187.5 calories/L
              0.91 X 187.5 = 170.6 calories/L
          2. Indications:
            1. Dehydration.
            2. Hypernatremi
            3. Drug administration.
          3. Possible side effects:
            1. Hypokalemi
            2. Osmotic diuresis - dehydration.
            3. Transient hyperinsulinism.
            4. Water intoxication.
        3. Five percent dextrose in normal salin
          1. Prevents ketone formation and loss of potassium and intracellular water.
          2. Indications:
            1. Hypovolemic shock - temporary measure
            2. Burns.
            3. Acute adrenocortical insufficiency.
          3. Same side effects as normal salin
        4. Isotonic multiple-electrolyte fluids - used for replacement therapy; ionic composition approximates blood plasm
          1. Types - Plasmanate, Polysol, and lactated Ringer’s.
          2. Indicated in: vomiting, diarrhea, excessive diuresis, and burns.
          3. Possible side effect - circulatory overloa
          4. Lactated Ringers is contraindicated tn severe metabolic acidosis and/or alkalosis and liver diseas
          5. Same side effects as normal saline
      2. Hypertonic solutions - fluids with an osmolarity much higher than 310 mOsm (+50 mOsm); increase osmotic pressure of blood plasma, thereby drawing fluid from the cells.
        1. Ten percent dextrose in normal salin
          1. Administered in large vein to dilute and prevent venous traum
          2. Used for nutrition and to replenish Na + and Cl".
          3. Possible side effects:
            1. Hypernatremia (excess Na ' ).
            2. Acidosis (excess Cl").
            3. Circulatory overloa
        2. Sodium chloride solutions, 3% and 5%.
          1. Slow administration essential to prevent overload (100 mL/hr).
          2. Indicated in water intoxication and severe sodium depletion.
      3. Hypotonic solutions - fluids whose osmolarity is significantly less than that of blood plasma ( - 50 mOsm); these fluids lower plasma osmotic pressures, causing fluid to enter cells.
        1. 0.45% sodium chloride - used for replacement when requirement for Na + use is questionabl
        2. 5% dextrose in 0.45% saline, also 5% D in 0.2% NaCI - common rehydrating solution.
          1. Indications:
            1. Fluid replacement when some Na + replacement is also necessary.
            2. Encourage diuresis in patients who are dehydrate
            3. Evaluate kidney status before instituting electrolyte infusions.
          2. Possible side effects:
            1. Hypernatremi
            2. Circulatory overloa
            3. Use with caution in edematous patients with cardiac, renal, or hepatic diseas
            4. After adequate renal function is established, appropriate electrolytes should be given to avoid hypokalemi
      4. Alkalizing agents - fluids used in the treatment of metabolic acidosis:
        1. Ringer’s:
          1. Administration - rate usually not more than 300 mL/hr.
          2. Side effects - observe carefully for signs of alkalosis.
        2. Sodium bicarbonate:
          1. Indications:
            1. Replace excessive loss of bicarbonate ion.
            2. Emergency treatment of lifethreatening acidosis.
          2. Administration:
            1. Depends on patient’s weight, condition, and carbon dioxide level.
            2. Usual dose is 500 mL of a 5% solution (89 mEq).
          3. Side effects:
            1. Alkalosis.
            2. Hypocalcemic tetany.
            3. Rapid infusion may induce cellular acidity and deat
      5. Acidifying solutions - fluids used in treatment of metabolic alkalosis.
        1. Types:
          1. Normal saline
          2. Ammonium chloride
        2. Administration - dosage depends on patient’s condition and serum lab values.
        3. Side effects:
          1. Hepatic encephalopathy in presence of decreased liver function because ammonia is metabolized by liver.
          2. Toxic effects of irregular respirations, twitching, and bradycardi
          3. Contraindicated with renal failur
      6. Blood and blood products
        1. Indications:
          1. Maintenance of blood volum
          2. Supply red blood cells to maintain oxygen-carrying capacity.
          3. Supply clotting factors to maintain coagulation properties.
          4. Exchange transfusion.

  4. Intravenous cancer chemotherapy
    1. Usual sites: forearm, dorsum of hand, wrist, antecubital foss
    2. Procedure:
      1. Normal saline infusion usually started first, to verify vein patency, position of needl Chemotherapy “piggybacked” into IV line that is runnin
      2. Rate: usually 1 mL/min. Running slowly decreases nausea, vomiting, and the degree of vein damag
      3. Check vein patency every 3-5 minutes.
      4. If more than one drug is to be infused, normal saline should be infused between drugs.
      5. Never infuse against resistanc
      6. Stop treatment if patient reports pain at needle sit Extravasation (infiltration of toxic drugs into tissue surrounding vessel) may be present.
      7. If extravasation present, begin protocol appropriate to drug administered (, flushing of line with saline, applying ice or heat, local injection of site with antidote drugs, topical application of steroid creams).
      8. Once treatment is completed, remove needle, apply Band-Aid, exert pressure to prevent hematoma formation.


Transfusion with Blood or Blood Products

Blood or Blood Product Indications Asessment: Side effects Nursing Care Plan/Implementation
Whole blood
  1. Acute hemorrhage
  2. Hypovolemic shock
  1. Hemolytic reaction
  2. Fluid overload
  3. Febrile reaction
  4. Pyrogenic reaction
  5. Allergic reaction
  1. Protocol for checking blood before transfusion is begun varies with each institution; however, at least two RNs must verify that the unit of blood has been crossmatched for a specific patient
See whole blood
Red blood cells, packed
  1. Acute anemia with hypoxia
  2. Aplastic anemia
  3. Bone marrow failure due to malignancy
  4. Patients who need red blood cells but not volume
See Whole Blood See Whole Blood
Red blood cells, frozen
  1. See Red blood cells, packed
  2. Patients sensitized by previous transfusions
  1. Less likely to cause antigen reaction
  2. Decreased possibility of transmitting hepatitis
See Whole Blood
White blood cells (leukocytes) Currently being used in severe leukopenia with infection (research still being done)
  1. Elevated temperature
  2. Graft-versus-host disease
  1. Careful monitoring of temperature
  2. Must be given as soon as collected
Platelet concentrate
  1. Severe deficiency
  2. Patients who have thrombocytopenia and are bleeding, with platelet counts below 10,000/p.L
  1. Fever, chills
  2. Hives
  3. Development of antibodies that will destroy platelets in future transfusions
Contraindications:
  1. Idiopathic thrombocytopenic purpura
  2. Disseminated intravascular coagulation (DIG)
Monitor temperature
See Single-donor fresh plasma
  1. Clotting deficiency or concentrates not available or deficiency not fully diagnosed
  2. Shock
  1. Side effects rare
  2. Heart failure
  3. Possible hepatitis
Use sterile, pyrogen-free filters
Plasma removed from whole blood (up to 5 days after expiration date, which is 21 days)
  1. Shock due to loss of plasma
  2. Burns
  3. Peritoneal injury
  4. Hemorrhage
  5. While awaiting blood crossmatch results
See Single-donor fresh plasma See Single-donor fresh plasma
Freeze-dried plasma See Plasma removed from whole blood Single-donor fresh-frozen plasma
  1. Notify blood bank to thaw about 30 min before administration
  2. Give immediately
Cryoprecipitate concentrate (factor VIII—antihemophilic factor) For hemophilia:
  1. Prevention
  2. Preoperatively
  3. During bleeding episodes
Rare 0.55 mL of cryoprecipitate concentrate has same effect on serum level as 1600 mL of fresh-frozen plasma
Factors II, VII, IX, and X compiled Specific deficiencies HepatitisCommercially prepared Commercially prepared
Fibrinogen (factor I) Fibrinogen deficiency Increased risk of hepatitis because the hepatitis virus combines with fibrinogen
  1. Reconstitute with sterile
  2. Do not warm fibrinogen or use hot water to reconsti-
  3. Do not shake
  4. Must be given with a filter
Albumin or salt-poor albumin
  1. Shock due to hemorrhage, trauma, infection, surgery, or
  2. TYeatment of cerebral edema
  3. Low serum-protein levels
None; these are heat-treated products Commercially prepared
Dextran Hypovolemic shock
  1. Rare allergic reaction
  2. Patients with heart or kidney disease susceptible to heart failure or pulmonary edema
Commercially prepared


Complications of IV Therapy
Assesment
Complication Subjective Data Objective Data Nursing Care Plan/Implementation
Infiltration-fluid infusing into surrounding tissue rather than into vessel
Pain around needle insertion
  1. Infusion rate slow
  2. Swelling, hardness, coolness, blanching of tissue at site of needle
  3. Blood does not return into tubing when bag/bottle lowered
  4. Puffiness under surface of arm
  1. Stop IV
  2. Apply warm towel to area
  3. Restart at another site
  4. Record
Thrombophlebitis -inflammatory changes in vessel; thromboemboli -the development of venous clots within the inflamed vessel
Pain along the vein
Redness, swelling around affected area (red line)
  1. Stop IV
  2. Notify physician
  3. Cold compresses or warm towel, as ordered
  4. Restart in another site
  5. Rest affected limb; do not rub
  6. Mursing care of thrombophlebitis
Pyrogenic reaction -contami- nated equipment/solution
  1. Headache
  2. Backache
  3. Nausea
  4. Anxiety
  1. Temperature increased
  2. Chills
  3. Face flushed
  4. Vomiting
  5. 1BP
  6. Cyanosis
  1. Discontinue IV
  2. Vital signs
  3. Send equipment for culture/analysis
  4. Antibiotic ointment, as ordered, at injection site
  5. Prevention: change tubing q24-48h; meticulous sterile technique; check for precipitation, expiration dates, damage to containers, tubings, etc.; refrigerate hyperalimentation fluids; discard hyperalimentation fluids that have been at room temperature for 8-12 hr and use new bag regardless of amount left in first bag (change, to prevent infection- excellent medium for bacterial growth)
Fluid overload -excessive amount of fluid infused; infants/elderly at risk
  1. Headache
  2. Shortness of breath
  3. Syncope
  4. Dyspnea
  1. Pulse increased, venous pressure
  2. Venous distention
  3. Flushed skin
  4. Coughing
  5. Respirations increased
  6. Cyanosis, pulmonary edema
  7. Shock
  1. Stop IV
  2. Semi-Fowler s position
  3. Notify physician
  4. Be prepared for diuretic therapy
  5. Preventive measures: monitor flow rate and patient’s response to IV therapy.
Air emboli -air in circulatory system
Loss of consciousness
  1. Hypotension, cyanosis
  2. Tachycardia
  3. venous pressure
  4. Tachypnea
  1. Turn on left side, with head down
  2. Administer oxygen therapy
  3. Medical emergency-call physician
Nerve damage -improper position of limb during infusion or tying limb down too tight during infusion-damage to nerve
Numbness: fingers, hands
Unusual position for limb
  1. Untie
  2. Passive ROM exercises
  3. Monitor closely for return of function
  4. Record limb status
Pulmonary embolism- blood clot enters pulmonary circulation and obstructs pulmonary artery
Dyspnea
  1. Orthopnea
  2. Signs of circulatory and cardiac collapse
  1. Slow IV to keep vein open (rate: 5-6 drops/minutes)
  2. Notify physician
  3. Medical emergency
  4. Be prepared for lifesaving measures and anticoagulation therapy